Rivaroxban limits adverse limb and cardiovascular events in surgically treated PAD patients

Posted by: admin Categories: Pulmonary Embolism

Rivaroxaban can be beneficial to patients with peripheral artery disease (PAD) who undergo surgical lower extremity revascularization (LER), ...

Source link

« An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen …

Delivering Covid vaccines as a nasal spray may work better »

Latest Tweets

Breathing+ by Breathing Labs has passed peer review in a randomized controlled clinical trial that was recently pub… twitter.com/i/web/status/15431…
July 2, 2022 11:37 am
BREAKING: @breathinglabs and @Nintendo clinical trial is published in journal Pediatric Pulmonology (SCI Q2, Impact… twitter.com/i/web/status/15404…
June 24, 2022 10:20 pm
Clinical mouthpieces 10pcs packages are now available at 45€/50USD (shipping cost not included). Learn more:… twitter.com/i/web/status/15000…
March 5, 2022 10:56 am
BREATHING VR: Lately we are sourcing this VR headset for use in Breathing VR application. It allows easiest install… twitter.com/i/web/status/13990…
May 30, 2021 3:52 pm
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be su… twitter.com/i/web/status/13328…
November 28, 2020 10:41 pm
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that… twitter.com/i/web/status/13237…
November 3, 2020 7:31 pm
Registration and all functionalities at breathinglabs.com (and in our iOS and Android games) are fixed and fu… twitter.com/i/web/status/12407…
March 19, 2020 10:50 pm
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys… twitter.com/i/web/status/11717…
September 11, 2019 12:00 pm
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial… twitter.com/i/web/status/11580…
August 4, 2019 5:55 pm

Home

How To Start

Q&A

Login

Rivaroxban limits adverse limb and cardiovascular events in surgically treated PAD patients

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE

IN MEDIA

Home

How To Start

Products

Breathing+ Package

Toys Package

Q&A

Login

Rivaroxban limits adverse limb and cardiovascular events in surgically treated PAD patients

You may also like...

104029-Heparin.doc – HEPARIN 1 Name class of drug u2013 generic and trade name GENERIC NAME Heparin Sodium BRAND NAME Hepalean Heparin Sodium Lock flush

Recurrent VTE and Bleeding With Apixaban vs. Rivaroxaban

Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE

IN MEDIA